The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease

C Choi; Y H Sohn; J H Lee; J Kim

doi:10.1016/s0022-510x(99)00198-7

The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease

J Neurol Sci. 2000 Jan 1;172(1):12-6. doi: 10.1016/s0022-510x(99)00198-7.

Authors

C Choi¹, Y H Sohn, J H Lee, J Kim

Affiliation

¹ Department of Neurology and the Brain Research Institute, Yonsei University College of Medicine, CPO Box 8044, Seoul, South Korea.

PMID: 10620654
DOI: 10.1016/s0022-510x(99)00198-7

Abstract

20) became non-depressed, while five patients (22%) among 23 initially non-depressed became depressed. With long-term levodopa therapy, the UPDRS-motor score significantly improved (35+/-15. 7-18+/-7.6), but the BDI score was unchanged (18+/-9.3-19+/-9.2). The initial BDI score was significantly and inversely correlated to the parkinsonian motor symptoms, but their percentage changes were not correlated to each other. These results provide strong support to previous observations that levodopa therapy does not alter parkinsonian depression as well as providing additional evidence to support the role of non-dopaminergic mechanisms in parkinsonian depression.

MeSH terms

Depressive Disorder / drug therapy*
Depressive Disorder / psychology
Female
Humans
Levodopa / administration & dosage*
Male
Middle Aged
Parkinson Disease / drug therapy*
Parkinson Disease / psychology
Psychiatric Status Rating Scales
Time Factors

Substances

Levodopa